ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,408Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 2888

$1.31M Total Retail Price of All Prescriptions

Rank: 109 out of 2888

603 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 603 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

15% of this provider’s 603 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 15,758 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$75 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 583 516 1 1
NEXIUM 533 471 2 19
FUROSEMIDE 517 481 3 6
TRAMADOL HCL 463 414 4 16
LISINOPRIL 442 402 5 3
SIMVASTATIN 420 404 6 2
ZOLPIDEM TARTRATE 418 376 7 17
DICLOFENAC SODIUM 414 367 8 141
HYDROCODONE-ACETAMINOPHEN 411 318 S3 9 4
OMEPRAZOLE 405 390 10 7
AMLODIPINE BESYLATE 369 340 11 5
METOPROLOL SUCCINATE 313 306 12 11
AZITHROMYCIN 307 275 13 38
METFORMIN HCL 291 262 14 8
ATORVASTATIN CALCIUM 280 253 15 9
ALENDRONATE SODIUM 278 257 16 23
CLOTRIMAZOLE-BETAMETHASONE 272 244 17 136
TAMSULOSIN HCL 262 259 18 29
METOPROLOL TARTRATE 259 230 19 10
DONEPEZIL HCL 257 254 20 26
LOVASTATIN 257 236 20 41
GABAPENTIN 216 173 22 13
CLOPIDOGREL 195 184 23 30
LANTUS 194 161 24 45
CIPROFLOXACIN HCL 192 179 25 47
NAMENDA 191 191 26 34
WARFARIN SODIUM 186 161 27 22
POTASSIUM CHLORIDE 181 171 28 14
CRESTOR 175 148 29 20
SERTRALINE HCL 165 153 30 27
LOSARTAN POTASSIUM 159 146 31 18
MECLIZINE HCL 151 146 32 122
PLAVIX 146 136 33 40
RANITIDINE HCL 142 136 34 56
GLYBURIDE-METFORMIN HCL 131 110 R 35 64
CLONIDINE HCL 129 105 36 39
PANTOPRAZOLE SODIUM 127 124 37 33
CLINDAMYCIN HCL 127 111 37 253
GLIMEPIRIDE 127 112 37 36
ESCITALOPRAM OXALATE 120 117 40 62
LEVOFLOXACIN 114 105 41 57
INSULIN SYRINGE 106 88 42 86
LOSARTAN-HYDROCHLOROTHIAZIDE 102 97 43 46
ISOSORBIDE MONONITRATE ER 101 80 44 51
POLYETHYLENE GLYCOL 3350 101 97 44 93
CITALOPRAM HBR 99 97 46 24
GLYBURIDE 98 91 R 47 58
FAMOTIDINE 96 87 48 75
DIGOXIN 85 83 49 55
GLIPIZIDE 77 75 50 50
CARBIDOPA-LEVODOPA 77 68 50 113
AMLODIPINE BESYLATE-BENAZEPRIL 75 70 52 67
KETOPROFEN 75 61 52 510
MEGESTROL ACETATE 73 73 R 54 140
HYDROCHLOROTHIAZIDE 73 71 54 15
JANUVIA 72 72 56 48
PREDNISONE 72 63 56 42
NAPROXEN 69 64 58 80
LACTULOSE 66 65 59 111
PRAVASTATIN SODIUM 63 60 60 12
MELOXICAM 63 62 60 31
AMOXICILLIN 62 53 62 117
IBUPROFEN 61 60 63 87
METOLAZONE 61 48 63 215
SYNTHROID 59 59 65 52
DEXAMETHASONE SODIUM PHOSPHATE 59 57 65 554
ENALAPRIL MALEATE 57 53 67 49
OXYBUTYNIN CHLORIDE ER 57 57 67 132
BYSTOLIC 56 56 69 99
ALBUTEROL SULFATE 55 55 70 134
LEXAPRO 55 51 70 198
SULFAMETHOXAZOLE-TRIMETHOPRIM 55 55 70 88
METFORMIN HCL ER 53 50 73 53
LIPITOR 52 42 74 78
FENTANYL 52 27 S2 74 126
DIOVAN HCT 51 51 76 61
ATENOLOL 51 48 76 25
RISPERIDONE 50 50 78 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.